内部人交易记录
董事基于 4 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the detailed record of transactions filed by Muir Glenn P, 董事. Insider active across 5 companies, notably REPLIGEN CORP. Aggregated, 25 reports have been logged. Split: 4 buys · 0 sell. Total volume traded: €67k. History available since 13 May 2021. The latest transaction was filed on 16 December 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Muir Glenn P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报25 总计
3,086 股Common StockSEC:0001181190-26-000007:0
3,366 股@ US$26.12100.0% 占其流量Common StockSEC:0001193125-25-322821:0
7,554 股0Common StockSEC:0001193125-25-246921:0
30,000 股Common StockSEC:0000950170-25-077824:0
973 股0Common StockSEC:0000950170-25-074752:0
44,444 股@ US$2.2558.8% 占其流量Common StockSEC:0000950170-25-017195:0
19,000 股@ US$36.2979.5% 占其流量Common StockSEC:0000950170-24-129145:0
20,000 股Common StockSEC:0000950170-24-107788:0
25,000 股@ US$0.8011.0% 占其流量Common StockSEC:0000950170-24-104427:0
12,776 股@ US$0.856.0% 占其流量Common StockSEC:0000950170-24-102437:0
25,000 股@ US$1.0013.7% 占其流量Common StockSEC:0000950170-24-099560:0
25,171 股@ US$0.7510.5% 占其流量Common StockSEC:0000950170-24-098142:0
5,000 股@ US$36.2920.5% 占其流量Common StockSEC:0000950170-24-089409:0
10,000 股0Common StockSEC:0001562180-24-005082:0
25,000 股Common StockSEC:0000950170-24-069564:0
701 股0Common StockSEC:0000950170-24-062597:0
10,000 股0Common StockSEC:0001562180-23-005270:0
36,364 股Common StockSEC:0001062993-23-012485:0
686 股0Common StockSEC:0000899243-23-013667:0
10,000 股0Common StockSEC:0001562180-22-005350:0
534 股0Common StockSEC:0000899243-22-020276:0
38,910 股Common StockSEC:0001062993-22-013869:0
4,389 股0Common StockSEC:0001562180-21-004394:0
7,137 股Common StockSEC:0001062993-21-005245:0
457 股0Common StockSEC:0000899243-21-019712:0
About Muir Glenn P
Administrateur, MUIR GLENN P has made 24 filings. In the recent sample of 24 filings, purchases total 67369 EUR, sales total 0 EUR, and the filings run from 2021-05-17 to 2025-12-17. The recent filings concern Neuronetics, Inc., REPLIGEN CORP, G1 Therapeutics, Inc. and Repligen CORP, with the transaction nature shown as Attribution.